Fundraising Fox
Stemnovate
3 known investors
Find your way into Stemnovate
Sign up to see every warm intro you have to Stemnovate
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Stemnovate team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Stemnovate provides an integrated platform combining multiomics data, cell reprogramming technology, and mechanistic functional studies to accelerate drug discovery and clinical translation for rare diseases, neurodegenerative conditions, and other therapeutic areas across human and animal health. The company operates cellular biobanks, develops microphysiological systems for in vitro testing, and partners with pharmaceutical and academic institutions to reduce reliance on animal testing while enabling precision medicine research.
Investors · 3
How we know: Cambridge Angels group's portfolio page · Not right? Tell us
How we know: funding news · o2h.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountseed investment roundMay 2018
o2h ventures (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Stemnovate do?
- Stemnovate provides an integrated platform combining multiomics data, cell reprogramming technology, and mechanistic functional studies to accelerate drug discovery and clinical translation for rare diseases, neurodegenerative conditions, and other therapeutic areas across human and animal health. The company operates cellular biobanks, develops microphysiological systems for in vitro testing, and partners with pharmaceutical and academic institutions to reduce reliance on animal testing while enabling precision medicine research.
- Who are Stemnovate's investors?
- Stemnovate's investors include Cambridge Angels group, O2h Ventures.